Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Neurotox Res. 2014 Feb 19;26(2):115–129. doi: 10.1007/s12640-014-9456-1

Figure 2.

Figure 2

BrdU-positive nuclei co-localized with β-III-tubulin. Confocal z-stack image taken from representative striatal tissue section 1 week after METH. BrdU-positive nuclei are labeled in green with FITC (A) and β-III-tubulin-positive progenitors are labeled with Cy3 in red (B). Co-labeled cells can be seen in the same striatal tissue section (C) identified by arrows. Significant one-way ANOVA revealed the percentage of BrdU-positive nuclei co-labeled with β-III-tubulin peaked at 1 week but was significantly less at all other times after METH (D), **p<0.01 (n=4).